Company

BioHarvest Sciences, Inc.

Headquarters: Vancouver, BC, Canada

Market Cap

$71.3 Million

USD as of Jan. 1, 2026

BioHarvest Sciences, Inc. Categories

Canada Healthcare Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

BioHarvest Sciences, Inc. market capitalization over time

Evolution of BioHarvest Sciences, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BioHarvest Sciences, Inc.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic

Company	Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien	$62.01 B
Zoetis Inc.	$55.81 B
Takeda Pharmaceutical Company Limited	$45.42 B
Haleon plc	$44.50 B
Teva Pharmaceutical Industries Limited	$35.85 B

Sector:

Company	Market Cap (USD)
Lilly	$968.50 B
Johnson & Johnson	$499.57 B
AbbVie	$405.28 B
Roche	$332.12 B
UnitedHealth Group	$304.72 B

Detailed Description

BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.

⛩️ Moltgate

Start charging for serious requests
in minutes.

Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.

Get Started Free

For professionals, services & 🦞 AI agents.

Stocks & Indices

BioHarvest Sciences, Inc. has the following listings and related stock indices.

Stock: OTC: CNVCF

Stock: CSE: BHSC

Stock: FSX: 8MV

Details

Headquarters:

Two Bentall Centre

Suite 1085 555 Burrard Street

Vancouver, BC V7X 1M8

Canada

Phone: 604 622 1186